Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-16

Clinical Trial Update: Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia [NA]

View source ↗

Summary

A completed trial evaluated the efficacy of darbepoetin alfa for treating renal anemia in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARANESP (DARBEPOETIN ALFA)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Anemia, Kidney Failure, Chronic | NA | Status: COMPLETED